- Home
- CYBN vs ESGL Comparison
CYBN vs ESGL Comparison
Compare CYBN & ESGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- ESGL
- Stock Information
- Founded
- CYBN 2019
- ESGL 1999
- Country
- CYBN Canada
- ESGL Singapore
- Employees
- CYBN N/A
- ESGL N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- ESGL
- Sector
- CYBN Health Care
- ESGL
- Exchange
- CYBN Nasdaq
- ESGL Nasdaq
- Market Cap
- CYBN 176.5M
- ESGL 154.7M
- IPO Year
- CYBN N/A
- ESGL N/A
- Fundamental
- Price
- CYBN $6.07
- ESGL $3.98
- Analyst Decision
- CYBN Strong Buy
- ESGL
- Analyst Count
- CYBN 3
- ESGL 0
- Target Price
- CYBN $85.00
- ESGL N/A
- AVG Volume (30 Days)
- CYBN 673.9K
- ESGL 30.6K
- Earning Date
- CYBN 11-12-2025
- ESGL 09-23-2025
- Dividend Yield
- CYBN N/A
- ESGL N/A
- EPS Growth
- CYBN N/A
- ESGL N/A
- EPS
- CYBN N/A
- ESGL N/A
- Revenue
- CYBN N/A
- ESGL $5,511,665.00
- Revenue This Year
- CYBN N/A
- ESGL N/A
- Revenue Next Year
- CYBN N/A
- ESGL N/A
- P/E Ratio
- CYBN N/A
- ESGL N/A
- Revenue Growth
- CYBN N/A
- ESGL N/A
- 52 Week Low
- CYBN $4.81
- ESGL $0.90
- 52 Week High
- CYBN $13.88
- ESGL $4.32
- Technical
- Relative Strength Index (RSI)
- CYBN 45.10
- ESGL 60.55
- Support Level
- CYBN $5.72
- ESGL $3.55
- Resistance Level
- CYBN $6.52
- ESGL $4.32
- Average True Range (ATR)
- CYBN 0.30
- ESGL 0.32
- MACD
- CYBN 0.05
- ESGL 0.01
- Stochastic Oscillator
- CYBN 38.48
- ESGL 62.05
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
About ESGL ESGL Holdings Limited
ESGL Holdings Ltd is a waste management, treatment, and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical, and electroplating companies.